INTERPACE BIOSCIENCES, INC. (IDXG) Operating income 2016–2025
INTERPACE BIOSCIENCES, INC. (IDXG) annual operating income history from SEC filings — each fiscal year as reported.
$4.1MFY2025 · since FY2016: -$6.4M → $4.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.1M | -49.6% |
| FY2024 | $8.1M | +105.0% |
| FY2023 | $4.0M | +209.4% |
| FY2022 | -$3.6M | +42.9% |
| FY2021 | -$6.3M | +75.7% |
| FY2020 | -$26.1M | +1.4% |
| FY2019 | -$26.4M | -109.3% |
| FY2018 | -$12.6M | -100.7% |
| FY2017 | -$6.3M | +2.3% |
| FY2016 | -$6.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IDXG financial trends
IDXG RevenueIDXG Net incomeIDXG Net marginIDXG Gross profitIDXG Gross marginIDXG Operating marginIDXG Operating cash flowIDXG Free cash flowIDXG Capital expendituresIDXG Return on equityIDXG Stock buybacksIDXG Dividends paidIDXG Total assetsIDXG Total liabilitiesIDXG Shareholders’ equityIDXG overview →